Literature DB >> 32156531

Three-dimensional printing technology as a promising tool in bioavailability enhancement of poorly water-soluble molecules: A review.

Olivier Jennotte1, Nathan Koch2, Anna Lechanteur3, Brigitte Evrard3.   

Abstract

Poor aqueous solubility of active pharmaceutical ingredients (API) is nowadays a major issue in the pharmaceutical field. The combinatorial chemistry provides more and more API with a great therapeutic potential, but with a low aqueous solubility. Among the strategies to overcome this drawback, the use of amorphous solid dispersions (ASD), as well as the increase of surface area, is widely used. The three dimensional (3D) printing technologies appear to be innovative tools allowing the construction of any unconventional forms with different composition, structure or infill; especially by using ASD materials. This review aims to deliver notions about the different 3D printing techniques found in the literature to improve aqueous solubility of several API, namely nozzle-based method, inkjet methods and laser- based methods, as well as guide formulator in terms of formulation parameters that have to be optimized to allow the most suitable impression of innovative medicines.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aqueous solubility enhancement; Drug delivery systems; Pharmaceutics; Three-dimensional printing

Mesh:

Substances:

Year:  2020        PMID: 32156531     DOI: 10.1016/j.ijpharm.2020.119200

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  2 in total

1.  Supersaturable organic-inorganic hybrid matrix based on well-ordered mesoporous silica to improve the bioavailability of water insoluble drugs.

Authors:  Qiaoli Wu; Disang Feng; Zhengwei Huang; Minglong Chen; Dan Yang; Xin Pan; Chao Lu; Guilan Quan; Chuanbin Wu
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

Review 2.  Practicality of 3D Printed Personalized Medicines in Therapeutics.

Authors:  Hilda Amekyeh; Faris Tarlochan; Nashiru Billa
Journal:  Front Pharmacol       Date:  2021-04-12       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.